Related coverage linked through entity extraction aliases.
Mar 03, 2026
The AI in genomics market is estimated to grow from USD 1.97 billion in 2026 to USD 317.4 billion by 2040, while the drug discovery informatics market is expected to reach USD 11.18 billion by 2035, driven by machine learning integration and big data analytics.
Feb 26, 2026
Drug candidates designed via generative artificial intelligence are achieving a 90% success rate in Phase I safety trials in early 2026, nearly double the historical industry average of approximately 50%, while compressing development timelines from six years to under 18 months.
Feb 13, 2026
The Emirates Drug Establishment unveiled the InSilico Medicine project at World Health Expo 2026, using AI and digital models to reduce drug development costs and accelerate pharmaceutical research. EDE signed an MoU with InSilico Medicine AI Limited to formalize the collaboration.
Feb 18, 2026
The global AI in biotechnology market was valued at USD 1,033 million in 2024 and is projected to reach USD 1,971 million by 2031, growing at a CAGR of 10.6%. A separate AI in precision medicine market is forecast to reach $38.88 billion by 2034 with a 35.5% CAGR.
